Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Pebblebrook Hotel Trust
PEB
$2.15B
| $11.1M | ﹤0.01% |
976,804
-1,718,544
| -64% | -$18.5M |
|
1577
PUT
uniQure
QURE
$3.07B
| $11.1M | ﹤0.01% |
190,300
+90,300
| +90% | +$1.64M |
|
1578
CALL
Alcoa
AA
$12.6B
| $11.1M | ﹤0.01% |
+337,300
| New | +$10.5M |
|
1579
Eagle Materials
EXP
$6.7B
| $11.1M | ﹤0.01% |
47,601
+2,814
| +6% | +$638K |
|
1580
Federated Hermes
FHI
$4.78B
| $11.1M | ﹤0.01% |
213,504
+162,609
| +319% | +$8.25M |
|
1581
Simply Good Foods
SMPL
$989M
| $11.1M | ﹤0.01% |
445,851
+57,767
| +15% | +$1.71M |
|
1582
Joby Aviation
JOBY
$7.67B
| $11.1M | ﹤0.01% |
685,458
-260,609
| -28% | -$3.96M |
|
|
TLN
1583
PUT
Talen Energy Corp
TLN
$15.8B
| $11.1M | ﹤0.01% |
+26,000
| New | +$9.39M |
|
1584
Kinross Gold
KGC
$30.5B
| $11.1M | ﹤0.01% |
444,745
+27,990
| +7% | +$538K |
|
|
PRMB
1585
CALL
Primo Brands
PRMB
$9.19B
| $11.1M | ﹤0.01% |
500,000
+349,800
| +233% | +$9.05M |
|
|
PRMB
1586
PUT
Primo Brands
PRMB
$9.19B
| $11.1M | ﹤0.01% |
+500,000
| New | +$12.9M |
|
1587
SS&C Technologies
SSNC
$18.6B
| $11M | ﹤0.01% |
124,482
-162,255
| -57% | -$14M |
|
1588
Supernus Pharmaceuticals
SUPN
$2.73B
| $11M | ﹤0.01% |
231,189
+90,250
| +64% | +$3.63M |
|
1589
Energy Fuels
UUUU
$3.11B
| $11M | ﹤0.01% |
719,354
+182,141
| +34% | +$1.93M |
|
|
QXO
1590
QXO Inc
QXO
$17.2B
| $11M | ﹤0.01% |
578,179
+231,623
| +67% | +$4.8M |
|
1591
Modine Manufacturing
MOD
$10.3B
| $11M | ﹤0.01% |
77,368
-37,577
| -33% | -$4.78M |
|
|
NUVL
1592
DELISTED
Nuvalent
NUVL
| $11M | ﹤0.01% |
126,880
-22,726
| -15% | -$1.8M |
|
1593
SLM Corp
SLM
$5.16B
| $10.9M | ﹤0.01% |
394,697
+119,103
| +43% | +$3.72M |
|
1594
iShares MSCI Mexico ETF
EWW
$1.97B
| $10.9M | ﹤0.01% |
160,037
+83,902
| +110% | +$5.24M |
|
1595
Phibro Animal Health
PAHC
$1.46B
| $10.9M | ﹤0.01% |
269,568
+86,719
| +47% | +$2.86M |
|
1596
PUT
Charter Communications
CHTR
$18.3B
| $10.9M | ﹤0.01% |
39,600
-35,700
| -47% | -$10.8M |
|
1597
Granite Construction
GVA
$5.4B
| $10.9M | ﹤0.01% |
99,352
-4,561
| -4% | -$469K |
|
1598
UGI
UGI
$7.62B
| $10.9M | ﹤0.01% |
326,682
+157,318
| +93% | +$5.5M |
|
|
CDTX
1599
DELISTED
Cidara Therapeutics
CDTX
| $10.9M | ﹤0.01% |
113,379
+83,755
| +283% | +$5.34M |
|
1600
Moog Inc Class A
MOG.A
$12.9B
| $10.8M | ﹤0.01% |
52,242
-15,235
| -23% | -$2.94M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.